393 related articles for article (PubMed ID: 23517078)
21. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
[TBL] [Abstract][Full Text] [Related]
23. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
24. PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.
Cardoso JC; Vieira FA; Gomes AS; Power DM
Peptides; 2007 Sep; 28(9):1902-19. PubMed ID: 17826180
[TBL] [Abstract][Full Text] [Related]
25. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.
Gonzalez-Rey E; Varela N; Chorny A; Delgado M
Curr Pharm Des; 2007; 13(11):1113-39. PubMed ID: 17430175
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.
Lee EH; Seo SR
BMB Rep; 2014 Jul; 47(7):369-75. PubMed ID: 24856828
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice.
Abad C; Tan YV
J Mol Neurosci; 2018 Sep; 66(1):102-113. PubMed ID: 30105629
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
Drahushuk K; Connell TD; Higgins D
J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Delgado M; Ganea D
J Immunol; 2000 Sep; 165(6):3051-7. PubMed ID: 10975815
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
32. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation.
Jóźwiak-Bębenista M; Kowalczyk E; Nowak JZ
Pharmacol Rep; 2015 Apr; 67(2):332-8. PubMed ID: 25712659
[TBL] [Abstract][Full Text] [Related]
33. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
Dickinson T; Fleetwood-Walker SM; Mitchell R; Lutz EM
Neuropeptides; 1997 Apr; 31(2):175-85. PubMed ID: 9179871
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms.
Braas KM; May V
Ann N Y Acad Sci; 1996 Dec; 805():204-16; discussion 217-8. PubMed ID: 8993404
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenylate cyclase-activating peptide and vasoactive intestinal peptide receptor expression in immortalized LHRH neurons.
Olcese J; McArdle CA; Middendorff R; Greenland K
J Neuroendocrinol; 1997 Dec; 9(12):937-43. PubMed ID: 9468019
[TBL] [Abstract][Full Text] [Related]
37. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
38. VIP, CRF, and PACAP act at distinct receptors to elicit different cAMP/PKA dynamics in the neocortex.
Hu E; Demmou L; Cauli B; Gallopin T; Geoffroy H; Harris-Warrick RM; Paupardin-Tritsch D; Lambolez B; Vincent P; Hepp R
Cereb Cortex; 2011 Mar; 21(3):708-18. PubMed ID: 20699230
[TBL] [Abstract][Full Text] [Related]
39. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
40. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.
Delgado M; Gonzalez-Rey E; Ganea D
FASEB J; 2004 Sep; 18(12):1453-5. PubMed ID: 15231725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
